White Label Pharma

White Label Pharma

Case Study

With thyroid eye disease (TED), the goal of today’s treatment is to preserve vision, as well as reduce symptoms. Current therapies are not truly disease-modifying. HCPs feel frustrated that they can’t act sooner to stop the longer-term consequences of TED, or offer their patients something better for improved QoL.

X